Virovek has collaborated with over 100 world-class universities, non-profit institutions and industry pioneers to deliver gene therapy applications for tomorrow.
The World’s Most Efficient Large-Scale AAV Manufacturing System
Virovek’s patented BAC-TO-AAV technology has the capability of generating up to 1E+17vg of adeno-associated virus in a single run. Learn more about our technology platform and explore a wide range of applications.
